Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities

American Journal of Surgery

Volumn 171, Issue 4, 1996, Pages 416-420

  Papa, Moshe Z ^a,b   Klein, Ehud ^a,b   Kami, Tamar ^a,b   Koller, Moshe ^a,b   Davidson, Benny ^a,b   Azizi, Ester ^a,b   Ben Ari, Gur ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIMB PERFUSION; LIMB TUMOR; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MELANOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0029976196     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)89621-3     Document Type: Article

References (22)

1. Creech O Jr., Krementz ET, Winblad JN. Experiences with isolation perfusion technics in the treatment of cancer. Ann Surg. 1959;149:627-640.
2. Creech O, Krementz ET, Ryan RF. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg. 1958; 148:616-632.
3. Stehlin JS, Clark R, White E. Regional chemotherapy for cancer: experiences with 116 perfusions. Ann Surg. 1960;151:605-619.
4. Thompson JF, Gianoutsos MP. Isolated limb perfusion for melanoma: effectiveness and toxicity of Cisplatin compared with that of melphalan and other drugs. World J Surg. 1992;16:227-233.
5. Hild P, Aigner K, Henneking K. Levels of cisplatinum in hyperthermic isolated perfusion. Cancer Res. 1983;2:255-256.
6. Klein ES, Ben-Ari GY. Isolation perfusion with cisplatin for malignant melanoma of the limbs. Cancer. 1987;59:1068-1071.
7. Roseman JM. Effective management of extremity cancers using cisplatin and etoposide in isolated limb perfusions. J Surg Oncol. 1987;35:170-172.
8. Pommier RF, Moseley HS, Cohen J. Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities. Am J Surg. 1988;155:667-671.
9. Balch CM. Management of regional metastatic melanoma. In: Balch CH, Milton GW, Shaw HM, Soong SJ, eds. Cutaneous Melanoma. Philadelphia: JB Lippincott; 1985:124-128.
10. Stehlin JS Jr. Hyperthermic perfusion with chemotherapy for cancer of the extremities. Surg Gynecol Obstet. 1969;129:305-308.
11. Briele HA, Schneeboum S, Barnicle M, Briele CS. Method of measurement for volume of an extremity, Surg Gynecol Obst. 1989; 169:349-351.
12. Bines SD, McBride CM. Isolated perfusion of the extremity for melanoma. In: Economou SG, ed. Adjuncts to Cancer Surgery. Philadelphia: Lea & Fabiger Publications; 1991:405-410.
13. Hofstrom L, Ruderstan CM, Blomquist E. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. J Clin Oncol. 1991;9: 12091-12092.
14. Patt YZ, Calvo DB, Benjamin RS. Treatment of regionally confined metastatic tumors with arterial infusion of cisplatin. In: Prestokyo AW, Crooke ST, Carter SK, eds. Cisplatin Current Status and New Developments. New York: Academic Press; 1980:495-509.
15. Lee Y-TM. Local-regional primary and recurrent melanoma, III: update of natural history and non-systemic treatment (1980-1987). Cancer Treat Rev. 1988;15:135.
16. Ghussen F, Nagel K, Groth W, et al. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg. 1984;200:764-768.
17. Krementz ET, Carter RD, Sutherland CM, et al. Regional chemotherapy for melanoma. A 35-year experience. Ann Surg. 1994;220: 520-535.
18. Hajarizadeh H, Mueller CR, Woltering EA, et al. Phase I-II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremities. Melanoma Res. 1991;1:55-61.
19. Fletcher WS, Pommier R, Small K. Results of cisplatin hyperthermic isolation perfusion for stage IIIA and IIIAB extremity melanoma. Melanoma Res. 1994; 4:17-19.
20. Santinami M, Belli F, Cascinelli N. Seven years experience with hyperthermic perfusion in extracorporeal circulation for melanoma of the extremities. J Surg Oncol. 1989;42:201-208.
21. Coit DG, Bajorin DF, Menendez-Botet C. A phase I trial of hyperthermic isolation limb perfusion (HILP) using cisplatin (CDDP) for metastatic melanoma. Proceedings of ASCO. 1991;10:294.
22. Wieberdink J, Benchhuysen C, Braat RP, et al. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol. 1982;18:905-910.